| 2022-02-22 | PAPADOPOULOS STELIOS | - | Sell | 84,515 | $19.56 | $1,653,113.40 | -6.5% | → |
| 2022-02-22 | FELDBAUM CARL B | - | Sale+OE | 20,000 | $19.49 | $389,800.00 | -70.1% | → |
| 2022-02-03 | Haley Patrick J. | EVP, Commercial | Sale+OE | 60,000 | $17.91 | $1,074,600.00 | -19.7% | → |
| 2021-12-15 | Lamb Peter | EVP, Scientific Strategy & CSO | Sale+OE | 47,500 | $17.44 | $828,400.00 | -11.6% | → |
| 2021-11-24 | Haley Patrick J. | EVP, Commercial | Sell | 17,236 | $17.25 | $297,321.00 | -6.8% | → |
| 2021-11-19 | FELDBAUM CARL B | - | Sale+OE | 20,000 | $17.62 | $352,400.00 | -70.1% | → |
| 2021-11-15 | Lamb Peter | EVP, Scientific Strategy & CSO | Sale+OE | 47,500 | $18.09 | $859,275.00 | -10.4% | → |
| 2021-11-01 | Hessekiel Jeffrey | EVP and General Counsel | Sell | 5,117 | $22.03 | $112,727.51 | -0.8% | → |
| 2021-10-15 | Lamb Peter | EVP, Scientific Strategy & CSO | Sale+OE | 47,500 | $21.92 | $1,041,200.00 | -10.4% | → |
| 2021-10-15 | Hessekiel Jeffrey | EVP and General Counsel | Sell | 12,883 | $22.02 | $283,683.66 | -2.0% | → |
| 2021-09-16 | Haley Patrick J. | EVP, Commercial | Sale+OE | 25,000 | $20.36 | $509,000.00 | -8.2% | → |
| 2021-09-15 | Lamb Peter | EVP, Scientific Strategy & CSO | Sale+OE | 47,500 | $20.46 | $971,850.00 | -10.9% | → |
| 2021-08-16 | Lamb Peter | EVP, Scientific Strategy & CSO | Sale+OE | 55,000 | $18.44 | $1,014,200.00 | -12.4% | → |
| 2021-07-15 | Lamb Peter | EVP, Scientific Strategy & CSO | Sale+OE | 60,000 | $17.47 | $1,048,200.00 | -13.3% | → |
| 2021-06-17 | Lamb Peter | EVP, Scientific Strategy & CSO | Sale+OE | 60,000 | $22.18 | $1,330,800.00 | -13.3% | → |
| 2021-05-18 | Haley Patrick J. | EVP, Commercial | Sell | 14,593 | $24.73 | $360,884.89 | -4.9% | → |
| 2021-05-17 | Hessekiel Jeffrey | EVP, General Counsel & Sec | Sell | 18,000 | $25.39 | $457,020.00 | -2.9% | → |
| 2021-05-14 | POSTE GEORGE | - | Sell | 40,802 | $24.97 | $1,018,825.94 | -20.6% | → |
| 2021-05-14 | MARCHESI VINCENT T | - | Sale+OE | 40,000 | $25.04 | $1,001,600.00 | -37.7% | → |
| 2021-05-13 | Schwab Gisela | Pres, Prod Dev & Med Aff & CMO | Sale+OE | 100,000 | $25.38 | $2,538,000.00 | -14.0% | → |
| 2021-05-11 | PAPADOPOULOS STELIOS | - | Sale+OE | 20,770 | $24.98 | $518,793.63 | -0.5% | → |
| 2021-05-11 | Freire Maria C | - | Sell | 8,275 | $25.01 | $206,957.75 | -20.6% | → |
| 2021-04-26 | Hessekiel Jeffrey | EVP and General Counsel | Sell | 18,000 | $25.03 | $450,540.00 | -2.8% | → |
| 2021-04-26 | Haley Patrick J. | EVP, Commercial | Sell | 7,665 | $25.03 | $191,854.95 | -2.5% | → |
| 2021-04-26 | Schwab Gisela | Pres, Prod Dev & Med Aff & CMO | Sale+OE | 50,000 | $25.00 | $1,250,000.00 | -7.5% | → |
| 2021-04-01 | Lamb Peter | EVP, Scientific Strategy & CSO | Sale+OE | 60,000 | $22.96 | $1,377,600.00 | -13.3% | → |
| 2021-04-01 | Schwab Gisela | Pres, Prod Dev & Med Aff & CMO | Sale+OE | 50,000 | $23.00 | $1,150,000.00 | -7.5% | → |
| 2021-03-29 | WYSZOMIERSKI JACK L | - | Sale+OE | 6,220 | $22.64 | $140,820.80 | -2.6% | → |
| 2021-03-15 | Garber Alan M | - | Sale+OE | 40,000 | $23.60 | $944,000.00 | -75.9% | → |
| 2021-03-01 | Lamb Peter | EVP, Scientific Strategy & CSO | Sale+OE | 65,000 | $22.11 | $1,437,150.00 | -16.0% | → |
| 2021-02-24 | COHEN CHARLES | - | Sale+OE | 40,000 | $22.69 | $907,600.00 | -18.1% | → |
| 2021-02-23 | WILLSEY LANCE | - | Sale+OE | 90,000 | $21.91 | $1,972,136.00 | -6.6% | → |
| 2021-02-22 | MARCHESI VINCENT T | - | Sell | 24,097 | $22.29 | $537,122.13 | -26.7% | → |
| 2021-02-18 | Schwab Gisela | Pres, Prod Dev & Med Aff & CMO | Sale+OE | 100,000 | $22.43 | $2,242,500.00 | -8.5% | → |
| 2021-02-16 | FELDBAUM CARL B | - | Sale+OE | 20,000 | $21.96 | $439,200.00 | -70.1% | → |
| 2021-02-12 | Haley Patrick J. | EVP, Commercial | Sell | 45,000 | $21.57 | $970,650.00 | -15.4% | → |
| 2021-02-01 | Lamb Peter | EVP, Scientific Strategy & CSO | Sale+OE | 65,000 | $22.08 | $1,435,200.00 | -18.7% | → |
| 2021-01-12 | Senner Christopher J. | EVP and CFO | Sale+OE | 30,000 | $25.00 | $750,000.00 | -10.9% | → |
| 2021-01-04 | Lamb Peter | EVP, Scientific Strategy & CSO | Sale+OE | 65,000 | $20.32 | $1,320,800.00 | -18.7% | → |
| 2020-12-18 | Lamb Peter | EVP, Scientific Strategy & CSO | Sale+OE | 65,000 | $20.01 | $1,300,650.00 | -18.7% | → |
| 2020-11-24 | MARCHESI VINCENT T | - | Sale+OE | 40,004 | $18.50 | $740,074.00 | -30.7% | → |
| 2020-11-10 | WYSZOMIERSKI JACK L | - | Sale+OE | 34,000 | $20.61 | $700,740.00 | -14.7% | → |
| 2020-10-21 | Hessekiel Jeffrey | EVP and General Counsel | Sale+OE | 39,742 | $21.95 | $872,336.90 | -10.4% | → |
| 2020-10-08 | Senner Christopher J. | EVP and CFO | Sale+OE | 10,000 | $25.00 | $250,000.00 | -7.3% | → |
| 2020-09-22 | Hessekiel Jeffrey | EVP and General Counsel | Sale+OE | 10,258 | $26.14 | $268,144.12 | -2.9% | → |